Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15696451rdf:typepubmed:Citationlld:pubmed
pubmed-article:15696451lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15696451lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:15696451lifeskim:mentionsumls-concept:C0030016lld:lifeskim
pubmed-article:15696451lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:15696451lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:15696451lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:15696451lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:15696451pubmed:issue1lld:pubmed
pubmed-article:15696451pubmed:dateCreated2005-2-7lld:pubmed
pubmed-article:15696451pubmed:abstractTextCardiovascular disease is the most common cause of mortality in patients with end-stage renal disease. Cardiovascular benefits of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been clearly established in the general population, but not in dialysis patients. This study examined statin prescription patterns and assessed the relationship between statin prescription and clinical outcomes in hemodialysis (HD) patients.lld:pubmed
pubmed-article:15696451pubmed:languageenglld:pubmed
pubmed-article:15696451pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15696451pubmed:citationSubsetIMlld:pubmed
pubmed-article:15696451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15696451pubmed:statusMEDLINElld:pubmed
pubmed-article:15696451pubmed:monthJanlld:pubmed
pubmed-article:15696451pubmed:issn1523-6838lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:YoungEric WEWlld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:SaitoAkiraAlld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:CombeChristia...lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:GillespieBren...lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:AkizawaTadaoTlld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:AkibaTakashiTlld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:BailieGeorge...lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:RaynerHugh...lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:Bragg-Gresham...lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:SatayathumSud...lld:pubmed
pubmed-article:15696451pubmed:authorpubmed-author:MasonNancy...lld:pubmed
pubmed-article:15696451pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15696451pubmed:volume45lld:pubmed
pubmed-article:15696451pubmed:ownerNLMlld:pubmed
pubmed-article:15696451pubmed:authorsCompleteYlld:pubmed
pubmed-article:15696451pubmed:pagination119-26lld:pubmed
pubmed-article:15696451pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:meshHeadingpubmed-meshheading:15696451...lld:pubmed
pubmed-article:15696451pubmed:year2005lld:pubmed
pubmed-article:15696451pubmed:articleTitleHMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.lld:pubmed
pubmed-article:15696451pubmed:affiliationCollege of Pharmacy, University of Michigan, College of Pharmacy, Ann Arbor, MI 48109-1065, USA. nmason@umich.edulld:pubmed
pubmed-article:15696451pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15696451pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15696451pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15696451pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15696451pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15696451lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15696451lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15696451lld:pubmed